StockDuty ← Dashboard Aug 03, 2026 07:42 PM ET
SignalFDA/Bio

Eli Lilly Granted FDA Breakthrough Therapy Status For Olomorasib In Pancreatic Cancer

Eli Lilly Granted FDA Breakthrough Therapy Status For Olomorasib In Pancreatic Cancer

What changed
Eli Lilly Granted FDA Breakthrough Therapy Status For Olomorasib In Pancreatic Cancer
Why it matters
Eli Lilly Granted FDA Breakthrough Therapy Status For Olomorasib In Pancreatic Cancer — impact context not separately stored; see What changed.
Sources
eodhd
Related signals
PHASE 1 OF INDIA - US TRADE PACT HINGES ON SECTION 301 PROBE , OFFICIAL SAYS →PITNEY BOWES OUTLINES PHASE 2 STRATEGIC REVIEW WHILE PUSHING NEAREST DEBT MATURITY TO MARCH 2029 - SEEKINGALPHA →UNICYCIVE PLUMMETS FOLLOWING SECOND CRL FOR OLC FOR HYPERPHOSPHATEMIA - SEEKINGALPHA →